Compile Data Set for Download or QSAR
maximum 50k data
Found 96 with Last Name = 'takeda' and Initial = 'n'
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM25117(AG-013736 | AXITINIB | N-methyl-2-({3-[(E)-2-(pyri...)
Affinity DataIC50:  0.910nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytochrome P450 2C9(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352206(CHEMBL1825089)
Affinity DataIC50:  1nMAssay Description:Inhibition of CYP2C9 using a fluorescent probe 7-methoxy-4-trifluoromethylcoumarinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316168(2-[(3-{[4-(3-{2-[2-(2-aminoethoxy)ethoxy]ethyl}ure...)
Affinity DataIC50:  2.80nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316167(2-[(3-{[4-(3-{2-[2-(2-hydroxyethoxy)ethoxy]ethyl}u...)
Affinity DataIC50:  2.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352202(CHEMBL1825101)
Affinity DataIC50:  3nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316133(2-[(3-{[4-(3-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}u...)
Affinity DataIC50:  3.10nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316132(2-({3-[(4-{3-[2-(2-methoxyethoxy)ethyl]ureido}phen...)
Affinity DataIC50:  3.40nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316169(2-{[3-({4-[3-(2-{2-[2-(dimethylamino)ethoxy]ethoxy...)
Affinity DataIC50:  3.5nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316153(2-{[3-({4-[(2,5,8,11-tetraoxatridecane-13-yl)amino...)
Affinity DataIC50:  3.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316151(2-({3-[(4-{[2-(2-methoxyethoxy)ethyl]amino}phenyl)...)
Affinity DataIC50:  3.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316134(2-{[3-({4-[3-(2,5,8,11-tetraoxatridecane-13-yl)ure...)
Affinity DataIC50:  3.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316135(2-{[3-({4-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl...)
Affinity DataIC50:  3.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352200(CHEMBL1825100)
Affinity DataIC50:  4nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM312269(2-{[3-({3-[3-(2-methoxyethyl)ureido]phenyl}ethynyl...)
Affinity DataIC50:  4nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316152(2-[(3-{[4-({2-[2-(2-methoxyethoxy)ethoxy]ethyl}ami...)
Affinity DataIC50:  4nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316145(N-{4-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  4.20nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316160(2-[(3-{[5-(3-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}u...)
Affinity DataIC50:  4.20nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316154(2-{[3-({4-[(2,5,8,11,14-pentaoxahexadecane-16-yl)a...)
Affinity DataIC50:  4.20nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316166(N-{6-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  4.30nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316131(2-{[3-({4-[3-(2-methoxyethyl)ureido]phenyl}ethynyl...)
Affinity DataIC50:  4.5nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316144(N-{3-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  4.60nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316072(2-({3-[(3-{3-[2-(2-methoxyethoxy)ethyl]ureido}phen...)
Affinity DataIC50:  4.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316147(N-{4-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  4.80nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316146(N-{4-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  4.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352208(CHEMBL1825090)
Affinity DataIC50:  5nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352215(CHEMBL1825093)
Affinity DataIC50:  5nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352212(CHEMBL1821761)
Affinity DataIC50:  5nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352209(CHEMBL1825092)
Affinity DataIC50:  5nMAssay Description:Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAurora kinase A(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352208(CHEMBL1825090)
Affinity DataIC50:  5nMAssay Description:Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316170(2-[(3-{[4-(3-{2-[2-(2-acetamideethoxy)ethoxy]ethyl...)
Affinity DataIC50:  5.10nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316141(2-[2-(2-methoxyethoxy)ethoxy]ethyl {4-[(6-{[2-(met...)
Affinity DataIC50:  5.20nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316157(2-[(3-{[6-(3-{2-[2-(2-methoxyethoxy)ethoxy] ethyl}...)
Affinity DataIC50:  5.5nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316173(6-[2-(methylcarbamoyl)phenylsulfanyl]-3-[2-(pyridi...)
Affinity DataIC50:  5.5nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316161(2-{[3-({5-[3-(2,5,8,11-tetraoxatridecane-13-yl)ure...)
Affinity DataIC50:  5.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316140(2-(2-methoxyethoxy)ethyl {4-[(6-{[2-(methylcarbamo...)
Affinity DataIC50:  5.80nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316083(2-[(3-{[3-(3-{2-[2-(2-methoxyethoxy)ethoxy]ethyl}u...)
Affinity DataIC50:  5.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316162(2-{[3-({5-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl...)
Affinity DataIC50:  5.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAurora kinase A(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352210(CHEMBL1825091)
Affinity DataIC50:  6nMAssay Description:Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352210(CHEMBL1825091)
Affinity DataIC50:  6nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352211(CHEMBL1825095)
Affinity DataIC50:  6nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316171(N-methyl-2-[(3-{[4-(3-{2-[2-(2-morpholinoethoxy)et...)
Affinity DataIC50:  6.10nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316142(2,5,8,11-tetraoxatridecane-13-yl {4-[(6-{[2-(methy...)
Affinity DataIC50:  6.40nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316085(2-{[(3-({3-[3-(2,5,8,11-tetraoxatridecane-13-yl)ur...)
Affinity DataIC50:  6.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Homo sapiens (Human))
Biogen Idec

Curated by ChEMBL
LigandPNGBDBM50352205(CHEMBL1825096)
Affinity DataIC50:  7nMAssay Description:Inhibition of CDK1/Cyclin B assessed as phosphorylation of Z-lyte Peptide at 0.017 to 30 nM by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316137(2-(2-methoxyethoxy)ethyl {3-[(6-{[2-(methylcarbamo...)
Affinity DataIC50:  7.20nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316139(2-methoxyethyl {4-[(6-{[2-(methylcarbamoyl)phenyl]...)
Affinity DataIC50:  7.60nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316130(2-{[3-({3-[3-(2,5,8,11,14-pentaoxahexadecane-16-yl...)
Affinity DataIC50:  7.70nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316163(N-{5-[(6-{[2-(methylcarbamoyl)phenyl]thio}-1H-inda...)
Affinity DataIC50:  7.90nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316143(2,5,8,11,14-pentaoxahexadecane-16-yl {4-[(6-{[2-(m...)
Affinity DataIC50:  8nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Senju Pharmaceutical

US Patent
LigandPNGBDBM316136(2-methoxyethyl {3-[(6-{[2-(methylcarbamoyl)phenyl]...)
Affinity DataIC50:  8.80nMAssay Description:Measurement of the kinase inhibitory activity of each compound produced in Examples was conducted using the Off-chip Mobility Shift Assay. For this t...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 96 total ) | Next | Last >>
Jump to: